Tenax Therapeutics Inc. (NASDAQ: TENX)
$3.37
+0.0050 ( +0.15% ) 5.8K
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
Market Data
Open
$3.37
Previous close
$3.36
Volume
5.8K
Market cap
$6.61M
Day range
$3.21 - $3.42
52 week range
$2.77 - $61.20
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Nov 13, 2023 |
def | Proxies and info statements | 4 | Oct 27, 2023 |
pre | Proxies and info statements | 4 | Oct 16, 2023 |
8-k | 8K-related | 14 | Sep 29, 2023 |
8-k | 8K-related | 15 | Aug 15, 2023 |
10-q | Quarterly Reports | 49 | Aug 14, 2023 |
8-k | 8K-related | 16 | Jul 19, 2023 |